Cubist Systematic Strategies’s Rocket Pharmaceuticals RCKT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.76M | Buy |
+718,781
| New | +$1.76M | 0.01% | 753 |
|
|
2025
Q1 | – | Sell |
-28,441
| Closed | -$357K | – | 2132 |
|
|
2024
Q4 | $357K | Buy |
+28,441
| New | +$357K | ﹤0.01% | 1060 |
|
|
2024
Q1 | – | Sell |
-7,319
| Closed | -$219K | – | 2698 |
|
|
2023
Q4 | $219K | Buy |
+7,319
| New | +$219K | ﹤0.01% | 1618 |
|
|
2022
Q4 | – | Sell |
-157,109
| Closed | -$2.51M | – | 3530 |
|
|
2022
Q3 | $2.51M | Buy |
+157,109
| New | +$2.51M | 0.01% | 1399 |
|
|
2022
Q2 | – | Sell |
-34,452
| Closed | -$546K | – | 3985 |
|
|
2022
Q1 | $546K | Sell |
34,452
-18,558
| -35% | -$294K | ﹤0.01% | 2464 |
|
|
2021
Q4 | $1.16M | Buy |
53,010
+51,210
| +2,845% | +$1.12M | 0.01% | 1809 |
|
|
2021
Q3 | $54K | Sell |
1,800
-5,162
| -74% | -$155K | ﹤0.01% | 2827 |
|
|
2021
Q2 | $308K | Sell |
6,962
-13,651
| -66% | -$604K | ﹤0.01% | 2314 |
|
|
2021
Q1 | $915K | Buy |
+20,613
| New | +$915K | 0.01% | 1593 |
|
|
2020
Q3 | – | Sell |
-9,261
| Closed | -$194K | – | 2610 |
|
|
2020
Q2 | $194K | Buy |
+9,261
| New | +$194K | ﹤0.01% | 2046 |
|
|
2020
Q1 | – | Sell |
-22,525
| Closed | -$513K | – | 2392 |
|
|
2019
Q4 | $513K | Buy |
+22,525
| New | +$513K | 0.01% | 1541 |
|
|
2017
Q1 | – | Sell |
-326
| Closed | -$8K | – | 1812 |
|
|
2016
Q4 | $8K | Buy |
326
+151
| +86% | +$3.71K | ﹤0.01% | 1661 |
|
|
2016
Q3 | $7K | Hold |
175
| – | – | ﹤0.01% | 1648 |
|
|
2016
Q2 | $5K | Hold |
175
| – | – | ﹤0.01% | 1668 |
|
|
2016
Q1 | $5K | Hold |
175
| – | – | ﹤0.01% | 1567 |
|
|
2015
Q4 | $8K | Sell |
175
-55
| -24% | -$2.51K | ﹤0.01% | 1709 |
|
|
2015
Q3 | $9K | Buy |
+230
| New | +$9K | ﹤0.01% | 1810 |
|